Markets:

Overview

News

Currencies

International

Treasuries

Neuronetics, Inc. - Common Stock (NQ:STIM)

1.425 +0.025 (+1.79%)

Streaming Delayed Price Updated: 12:32 PM EDT, Mar 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Neuronetics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Neuronetics (STIM) Q4 2025 Earnings Transcript ↗

March 17, 2026

Neuronetics (STIM) Q4 2025 Earnings Transcript

Via The Motley Fool

NEURONETICS INC (NASDAQ:STIM) Reports Q4 Revenue Beat but Shares Drop on Cautious Outlook ↗

March 17, 2026

Via Chartmill

Which stocks are experiencing notable movement on Wednesday? ↗

February 11, 2026

Via Chartmill

Top stock movements in today's session. ↗

February 11, 2026

Via Chartmill

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Earnings Scheduled For August 5, 2025 ↗

August 05, 2025

Via Benzinga

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

February 11, 2026

Via Chartmill

Get insights into the top gainers and losers of Wednesday's pre-market session. ↗

February 11, 2026

Via Chartmill

Wondering what's happening in today's after-hours session? ↗

February 10, 2026

Via Chartmill

Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November ↗

November 18, 2025

Via Benzinga

TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression

November 12, 2025

New Policy Update Brings Innovative, Non-Drug Depression Treatment to Adolescents Across 26 States

From Neuronetics

Via GlobeNewswire

Tuesday's pre-market session: top gainers and losers ↗

November 04, 2025

The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

NEURONETICS INC (NASDAQ:STIM) Stock Plummets 22% on Q3 2025 Revenue Miss ↗

November 04, 2025

Neuronetics (STIM) Q3 2025 results: revenue miss sparks a 22% stock drop despite a narrower-than-expected EPS loss.

Via Chartmill

Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence

October 30, 2025

New collaboration provides services to streamline patient support, reduce administrative burden, and expand access to advanced TMS treatment across Elite DNA Clinics

From Neuronetics

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 06, 2025

Via Benzinga

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

September 17, 2025

Over 5 million New York Medicaid members to gain access to Transcranial Magnetic Stimulation (TMS) services

From Neuronetics

Via GlobeNewswire

Neuronetics Inc (NASDAQ:STIM) Reports Mixed Q2 2025 Earnings: Revenue Beat Overshadowed by Wider-Than-Expected Loss ↗

August 05, 2025

Neuronetics (STIM) reported mixed Q2 2025 results, beating revenue estimates but posting a wider-than-expected loss, causing a 9% pre-market drop. Greenbrook clinics hit record revenue.

Via Chartmill

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

July 30, 2025

Real-world data showing NeuroStar is effective in adolescents and young adults with depression from the world’s largest TMS outcomes dataset

From Neuronetics

Via GlobeNewswire

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program

June 10, 2025

NeuroStar, a Silver Sponsor at CTMSS, will also present two posters as part of the Company’s ongoing commitment to clinical innovation and excellence

From Neuronetics

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 27, 2025

Via Benzinga

Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month

May 14, 2025

From Neuronetics

Via GlobeNewswire

Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression

March 31, 2025

Policy update increases access for millions covered by Evernorth Health Services

From Neuronetics

Via GlobeNewswire

Earnings Scheduled For March 4, 2025 ↗

March 04, 2025

Via Benzinga

What's going on in today's pre-market session ↗

February 07, 2025

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 07, 2025

Via Benzinga

These stocks are moving in today's after hours session ↗

February 06, 2025

Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression

January 29, 2025

Advancing mental health treatment through innovative research, offering insights on symptom improvement and clinical tools

From Neuronetics

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 12, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.